Pope Francis to be released from the hospital

Pope Francis to be released from the hospital


A rose and and an image of Pope Francis are placed at the statue of late Pope John Paul II outside Gemelli Hospital, where Pope Francis is admitted for treatment, in Rome, Italy, Feb. 27, 2025.

Yara Nardi | Reuters

Pope Francis is scheduled to be discharged from the hospital on Sunday, his doctors said Saturday.

Francis, 88, was hospitalized more than five weeks ago for bronchitis. At times, the pope was in critical condition and required high-flow oxygen therapy, according to the Vatican.

Francis, who has chronic lung disease, has battled ongoing health issues in recent years. Throughout his illness, the Vatican has maintained that Francis has carried out his duties. However, he has remained out of the public eye for weeks.

This is breaking news. Please check back for updates.



Source

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World
World

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, bitcoin falls as Wall Street rethinks some AI investments. Also, CF Benchmarks CEO Sui Chung discusses recent trends in crypto ETFs. Source

Read More
The chart that has Michael Burry worried about the stock market
World

The chart that has Michael Burry worried about the stock market

Michael Burry is warning that a shift in household wealth could leave the stock market vulnerable to a long and significant downturn. “The Big Short” investor pointed to a graphic produced by Wells Fargo showing that U.S. households now hold a larger share of their net worth in equities than in real estate — a […]

Read More
This biotech name is evolving into a major obesity play. How to trade it with options
World

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra […]

Read More